Genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae Gulf in Dubai, and the joint effort with leading clinicians from the region, including cardiologist Dr. Ibrahim Al Rashdan.
“There is an exponentially growing demand for combining efforts between the Gulf region and the West, in terms of high quality but cost-conscious clinical research”, said Dr. Al Rashdan. “It combines the vision and guidance on evidence based medicine of our group in the Middle East with the proven CRO model of genae in the Americas and Europe.”
Dr. Al Rashdan was involved in numerous cardiovascular clinical trials as Principal Investigator and serves as Course Director of the Gulf PCR congress.
“By combining our mutual expertise in health care and clinical research, in symphony with local culture and regulations, this collaboration is truly about building bridges in the pursuit of advancing sponsored clinical trials”, said Bart Segers, CEO at genae.
Dubai is an icon of entrepreneurship and modernity in the Arab world. As the second largest emirate behind Abu Dhabi, the capital of the UAE, Dubai is globally recognized as the Middle East region’s international business hub. Since 2000 real GDP of Dubai has been growing at a CAGR of about 15%. In 2009, 95% of Dubai’s GDP came from non-oil sectors, a unique differentiator in a region where economies are dependent on oil incomes. The metropolis is offering outstanding infrastructure, a state-of-the-art telecommunications network and unparalleled connectivity.